Basit öğe kaydını göster

dc.contributor.authorŞahin, Eda Adeviye
dc.contributor.authorToprak, Serhat
dc.contributor.authorSayal, Hasan Berkan
dc.contributor.authorEkinci, Tekin
dc.contributor.authorYılmaz, Ercan
dc.contributor.authorBakay, Kadir
dc.contributor.authorMelekoğlu, Rauf
dc.contributor.authorSezgin, Burak
dc.contributor.authorTohma, Yusuf Aytaç
dc.contributor.authorŞahin, Hanifi
dc.date.accessioned2022-07-04T11:06:25Z
dc.date.available2022-07-04T11:06:25Z
dc.date.issued2022en_US
dc.identifier.citationSahin, EA, Toprak, S, Sayal, HB, et al. Analysis of prognostic factors in Grade 3 endometrioid type endometrial carcinoma. Int J Gynecol Obstet. 2022; 00: 1- 8. doi: 10.1002/ijgo.14277en_US
dc.identifier.issn0020-7292 / 1879-3479
dc.identifier.urihttps://doi.org/10.1002/ijgo.14277
dc.identifier.urihttps://hdl.handle.net/20.500.12809/10073
dc.description.abstractObjective To investigate the prognostic factors of patients with Grade 3 endometrioid endometrial cancer (G3EEC). Methods This four-center, retrospective study included a total of 129 women with G3EEC. Demographic, clinicopathologic, and survival data were collected. Kaplan-Meier method was used for survival analysis. Predictors of outcome were analyzed using Cox proportional hazards models. Results Median age at the time of diagnosis was 63 (range 39-87) years and median follow up was 37 (range 6-126) months. For the entire cohort, the 5-year disease-free survival (DFS) and overall survival (OS) were 54.3% and 63.6%, respectively. The 5-year DFS rates for lymphovascular space invasion (LVSI) -positive and -negative patients were 41.6% and 88.3%, respectively (P < 0.001). The 5-year OS rates for LVSI-positive and -negative patients were 54.7% and 88.3%, respectively (P = 0.001). Positive LVSI status was identified as the independent prognostic factor for decreased DFS and OS (hazard ratio [HR] 5.5, 95% confidence interval [CI] 1.65-18.86; P = 0.006 versus HR 4.4, 95% CI 1.33-14.58; P = 0.013, respectively). Conclusion LVSI seems to be an independent prognostic factor for decreased DFS and OS in G3EEC patients.en_US
dc.item-language.isoengen_US
dc.publisherWILEYen_US
dc.relation.isversionof10.1002/ijgo.14277en_US
dc.item-rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectEndometrial canceren_US
dc.subjectGrade3en_US
dc.subjectPrognostic factoren_US
dc.titleAnalysis of prognostic factors in Grade 3 endometrioid type endometrial carcinomaen_US
dc.item-typearticleen_US
dc.contributor.departmentMÜ, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümüen_US
dc.contributor.authorID0000-0003-2938-5816en_US
dc.contributor.institutionauthorSezgin, Burak
dc.relation.journalINTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICSen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster